We also observed a trend among the three breast cancer subtypes (HER2+, TNBC, and luminal tumors) such that patients with positive Ob-R tumors appeared to be more likely to achieve a pCR than patients with negative Ob-R tumors. The gene discussed is ERBB2; the disease is breast cancer.